N-Acetylcysteine (NAC)

A building block for the body's protective substance glutathione. I am testing it from October 2026.

Updated: October 2026

Structural formula of N-acetylcysteine

What is it?

N-acetylcysteine, NAC for short, is a form of the amino acid cysteine. For decades it has been used to loosen mucus in coughs, and in hospitals as an antidote to paracetamol overdose. NAC is interesting for Parkinson's because the body uses it to make glutathione, its most important natural protection against oxidative stress. In Parkinson's, glutathione levels in the substantia nigra, the area with the dopamine nerve cells, are clearly reduced at an early stage.

What does research say?

Earlier small studies at Thomas Jefferson University in Philadelphia had shown that NAC raises glutathione levels in the brain. Two new studies were published in 2026:

The annual overview of all Parkinson's trials also lists NAC among the phase 2 drugs meant to slow the disease (see Study Overview). Proof that NAC slows progression is still missing. But I find the direction of the results so far encouraging.

My experience

Since October 2026 I have been testing NAC, for six months to begin with. If you take NAC and other selenium as well, check how much selenium a product contains in addition (see supplements). I will add my experience here.

Safety

Effort and cost

NAC is inexpensive. In German pharmacies it is sold as a cough remedy with 600 mg, usually as effervescent tablets. Small packs are available over the counter, large packs of 100 only on prescription. As a supplement, NAC comes in capsules of 600 or 800 mg; depending on size, one pack lasts several months and costs about 20 to 35 euros.

My conclusion

For me, NAC is a well-tolerated and inexpensive building block that works exactly where Parkinson's shows a deficit: protecting nerve cells from oxidative stress. That is why I am trying it.